Kashiv Biosciences has a total of 241 patents globally, out of which 31 have been granted. Of these 241 patents, more than 60% patents are active. The United States of America is where Kashiv Biosciences has filed the maximum number of patents, followed by India and Canada. Parallelly, India seems to be the main focused R&D centre and also United States of America is the origin country of Kashiv Biosciences.
Kashiv Biosciences was founded in 2011. Kashiv BioSciences specializes in pharmaceutical research and drug delivery, creating enhanced versions of existing medicines. The company develops drug delivery platforms, healthcare technologies, and improved medicines to address unmet medical needs, particularly for cancer patients, improving their quality of life.
Do read about some of the most popular patents of Kashiv Biosciences which have been covered by us in this article and also you can find Kashiv Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Kashiv Biosciences patent portfolio.
How many patents does Kashiv Biosciences have?
Kashiv Biosciences has a total of 241 patents globally. These patents belong to 79 unique patent families. Out of 241 patents, 147 patents are active.
How Many Patents did Kashiv Biosciences File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Kashiv Biosciences Applications Filed | Kashiv Biosciences Patents Granted |
| 2024 | 1 | 5 |
| 2023 | 10 | 2 |
| 2022 | 62 | 5 |
| 2021 | 44 | 4 |
| 2020 | 33 | 2 |
| 2019 | 15 | – |
| 2018 | 23 | 1 |
| 2017 | 4 | 2 |
| 2016 | 8 | 6 |
| 2015 | 7 | 2 |
| 2014 | 8 | – |
Explore the top-performing drugs that dominate the Pharmaceutical Industry
| Patent Number | Company | Product | Brand | Revenue | Patent Expiry Date |
| US9174975 | Sumitomo Pharma | Lurasidone Hydrochloride | Latuda | $1.75B | Jun-26 |
| US7612199 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US7902206 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US8158644 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US7371727 | Ironwood Pharma | Linaclotide | Linzess | $1.00B | Mar-25 |
Want to know which drugs are making over $1 Billion annually?
How many Kashiv Biosciences patents are Alive/Dead?
Worldwide Patents
How Many Patents did Kashiv Biosciences File in Different Countries?
Countries in which Kashiv Biosciences Filed Patents
| Country | Patent |
| United States of America | 42 |
| India | 39 |
| Canada | 30 |
| Europe (EPO) | 27 |
| Australia | 18 |
| Japan | 8 |
| China | 3 |
| Brazil | 2 |
| Germany | 2 |
| Russian Federation | 2 |
| Italy | 1 |
| Austria | 1 |
| Spain | 1 |
Where are Research Centers of Kashiv Biosciences Patents Located?
10 Best Kashiv Biosciences Patents
WO2015120201A1 is the most popular patent in the Kashiv Biosciences portfolio. It has received 42 citations so far from companies like Acura Pharmaceuticals, Intellipharmaceutics, Grünenthal GmbH.
Below is the list of 10 most cited patents of Kashiv Biosciences:
| Publication Number | Citation Count |
| WO2015120201A1 | 42 |
| WO2015103379A1 | 31 |
| WO2018232413A1 | 16 |
| WO2014100403A1 | 15 |
| US8545759B2 | 14 |
| CN110996922A | 12 |
| WO2020006278A1 | 8 |
| WO2017070566A1 | 7 |
| CN105007899A | 5 |
| US8183035B1 | 4 |
What are Kashiv Biosciences key innovation segments?
What Technologies are Covered by Kashiv Biosciences?
The chart below distributes patents filed by Kashiv Biosciences in different countries on the basis of the technology protected in patents. It also represents the markets where Kashiv Biosciences thinks it’s important to protect particular technology inventions.
R&D Focus: How has Kashiv Biosciences search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!